Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume 310, Issue 3, Pages 710-714Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2003.09.069
Keywords
angiotensin; catecholamine; CATH.a cell; potassium current
Categories
Funding
- NHLBI NIH HHS [HL-33610, HL-49130] Funding Source: Medline
Ask authors/readers for more resources
Angiotensin II (Ang II) modulates, via Ang II type 1 (AT(1)) receptors, the activity of brain catecholaminergic neurons. Here we utilized catecholaminergic CATH.a cells to define the effects of Ang II on delayed rectifier K+ current (I-Kv) one of the factors that determines changes in neuronal activation. Receptor binding analyses demonstrated the presence of AT(1) receptors in CATH.a cells. Whole cell voltage clamp experiments in these cells revealed that Ang II (100 nM) produced a significant inhibition of I-Kv, that was abolished by the AT(1) receptor blocker, losartan (1 muM), or by inhibition of phospholipase C (PLC) with U73122 (10muM). Furthermore, this action of Ang II was completely abolished by co-inhibition of protein kinase C (PKC) and calcium/calmodulin protein kinase II (CaMKII). These results demonstrate that Ang II produces an inhibition of I-Kv in CATH.a cells, via an intracellular pathway that includes PLC, PKC, and CaMKII. (C) 2003 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available